Haemonetics Corp (HAE)

Cost of Revenue

$136.58M

Quarterly · Period ending: · USD

HAE logo

HAE Cost of Revenue

Latest reported$136.58M
HAE Quarterly Cost of Revenue ($0.00 → $136.58M)
High-resolution chart · PNG

HAE cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Haemonetics Corp Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
136,577,000
148,139,000
147,561,000
143,894,000
129,535,000
148,675,000
148,627,000
154,309,000
156,882,000
154,346,000
151,318,000
147,615,000
143,861,000
140,165,000
146,643,000
139,578,000
119,401,000
110,843,000
121,391,000
117,146,000
118,190,000
113,819,000
120,163,000
103,978,000
105,044,000
122,070,000
130,918,000
125,283,000
122,386,000
138,085,000
136,181,000
129,674,000
146,103,000
129,166,000
122,748,000
120,815,000
119,286,000
145,955,000
126,762,000
116,005,000
118,900,000
144,319,000
124,529,000
114,396,000
110,874,000
118,113,000
120,166,000
119,466,000
118,210,000
125,650,000
120,491,000
115,871,000
108,131,000
126,802,000
134,280,000
116,416,000
86,362,000
92,059,000
95,229,000
89,496,000
81,821,000
82,532,000
83,299,000
79,078,000
76,576,000
80,980,000
79,722,000
76,103,000
71,144,000
70,249,000
77,151,000
71,230,000
71,079,000
68,954,000
68,029,000
61,290,000
60,442,000
58,572,000
57,108,000
53,326,000
53,301,000
51,818,000
50,008,000
48,723,000
48,649,000
46,529,000
46,317,000
45,374,000
47,502,000
49,680,000
47,624,000
46,108,000
48,697,000
44,663,000
46,174,000
48,135,000
43,288,000
41,566,000
43,176,000
40,903,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.